Abstract:Triple-negative breast cancer (TNBC), which is estrogen receptor (ER)-negative, progesterone receptor-negative and is also negative for HER2 expression, remains a great clinical challenge due to its strong resistance to chemotherapy at the late stage of treatment and relatively unfavorable prognosis. Gemcitabine has been approved by the FDA/SFDA for use as a first-line therapeutic drug against advanced or metastatic breast cancer. Therefore, the clarification of the mechanisms underlying gemcitabine-acquired resistance is of particular importance for the optimal management of TNBC. A number of studies have revealed that autophagy, which has been found to protect cancer cells from anti-cancer drug-induced death, may contribute to the development of drug resistance. However, the association between autophagy and gemcitabine treatment in TNBC cells has yet to be defined. Our study clearly demonstrates that gemcitabine is able to induce mTOR-independent autophagy in human triple-negative MDA-MB-231 breast cancer cells. In addition, we demonstrate that autophagy protects MDA-MB-231 cells from gemcitabine-induced cell growth inhibition and apoptosis, indicating that gemcitabine can activate autophagy to impair the sensitivity of MDA-MB-231 cells. Furthermore, as shown by our results, the inhibition of gemcitabine-induced autophagy by chloroquine shifts the expression of the p53 protein, Bcl-2 family proteins and the relative Bax/Bcl-xL ratio in favor of promoting apoptosis. These results reveal that the inhibition of apoptosis may be one of the mechanisms of autophagy-induced cytoprotection in gemcitabine-treated MDA-MB-231 cells. The apoptotic and autophagic processes constitute a mutual inhibition system and jointly seal the fate of TNBC cells that are exposed to gemcitabine. Thus, our study suggests that the combination of an autophagic inhibitor and gemcitabine as a therapeutic strategy may represent a promising approach with greater clinical efficacy for patients with TNBC. However, extended preclinical trials are required to further determine the positive effects of the inhibition of autophagy on the efficacy of gemcitabine.

Effect of Bis(hydroxymethyl) Alkanoate Curcuminoid Derivative MTH-3 on Cell Cycle Arrest, Apoptotic and Autophagic Pathway in Triple-Negative Breast Adenocarcinoma MDA-MB-231 Cells: an in Vitro Study

[Corrigendum] Next‑generation Sequencing Analysis Reveals That MTH‑3, a Novel Curcuminoid Derivative, Suppresses the Invasion of MDA‑MB‑231 Triple‑negative Breast Adenocarcinoma Cells.

The Cytoprotective Role Of Gemcitabine-Induced Autophagy Associated With Apoptosis Inhibition In Triple-Negative Mda-Mb-231 Breast Cancer Cells

Curcumin-induced antitumor effects on triple-negative breast cancer patient-derived xenograft tumor mice through inhibiting salt-induced kinase-3 protein

MTH-3 Sensitizes Oral Cancer Cells to Cisplatin Via Regulating TFEB

Induction of Apoptosis and Regulation of MicroRNA Expression by (2E,6e)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) Treatment on MCF-7 Breast Cancer Cells

New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.

[Effect of Curcumin in Inducing Apoptosis of MDA-MB-213 Cells by Activating Endoplasmic Reticulum Stress].

Effects of Curcumin on Proliferation Inhibition and Apoptosis in Human Prostate Carcinoma PC-3M Cells

Curcumin Analogue Go-Y030 Inhibits Stat3 Activity And Cell Growth In Breast And Pancreatic Carcinomas

Curcumin metabolites induce autophagic cell death through PI3K/AKT‐mTOR signaling in COLO205 human colon adenocarcinoma cells

A Novel Microtubule Inhibitor, Mt3-037, Causes Cancer Cell Apoptosis by Inducing Mitotic Arrest and Interfering with Microtubule Dynamics

C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells

Design, Synthesis, Cytotoxic Evaluation, and Molecular Docking of New Alkyl Triphenylphosphonium Curcumin Derivatives

3-MA combined with TSA inhibits growth of triple-negative breast cancer cells

Activation of autophagy promotes the inhibitory effect of curcumin analog EF‐24 against MDA‐MB‐231 cancer cells

Synthesis And Biological Evaluation Of Curcumin Derivatives With Water-Soluble Groups As Potential Antitumor Agents: An In Vitro Investigation Using Tumor Cell Lines

Effects of Curcumin on Inducing Apoptosis in Human Bladder Cancer UMUC2 Cells

Curcumin Induces Apoptosis in Gallbladder Carcinoma Cell Line GBC-SD Cells

Curcuminoids Induce Reactive Oxygen Species and Autophagy to Enhance Apoptosis in Human Oral Cancer Cells.

Inhibitory Effects and Molecular Mechanisms of Tetrahydrocurcumin Against Human Breast Cancer MCF-7 Cells